Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Novel topoisomerase inhibitors identified by researchers at State U. of New Jersey

July 2, 2004

Retinoic metabolism inhibitors promising against prostate cancer

July 2, 2004

Exelixis submits IND for XL-999

July 2, 2004

FDA accepts IND for MN-029

July 2, 2004

Aplidin receives orphan drug status for ALL

July 2, 2004

Alimta receives positive opinion in Europe

July 1, 2004

Sanofi-Synthelabo and Pfizer conclude agreement on divestment of Campto

July 1, 2004

Preliminary data on Exherin in patients with solid tumors

July 1, 2004

Celecoxib and a poxvirus-based vaccine improve survival in mice with multiple intestinal neoplasia

July 1, 2004

Palifermin NDA submitted for oral mucositis

July 1, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....